Omada Health, Inc. (OMDA)
| Market Cap | 859.72M |
| Revenue (ttm) | 260.21M |
| Net Income (ttm) | -12.78M |
| Shares Out | 58.93M |
| EPS (ttm) | -0.35 |
| PE Ratio | n/a |
| Forward PE | 76.63 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 772,191 |
| Open | 14.69 |
| Previous Close | 14.72 |
| Day's Range | 14.44 - 15.00 |
| 52-Week Range | 10.28 - 28.40 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 21.73 (+48.94%) |
| Earnings Date | May 7, 2026 |
About OMDA
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for emplo... [Read more]
Financial Performance
In 2025, Omada Health's revenue was $260.21 million, an increase of 53.24% compared to the previous year's $169.80 million. Losses were -$12.78 million, -72.89% less than in 2024.
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for OMDA stock is "Buy." The 12-month stock price target is $21.73, which is an increase of 48.94% from the latest price.
News
Omada Health Helps Members on GLP‑1s Lose More Fat, Preserve Muscle Mass, and Improve Mental Health, New Study Finds
SAN FRANCISCO, April 17, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first provider of between-visit care, announced new study results demonstrating that Omada members in its GLP...
Omada Health to Announce First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026
SAN FRANCISCO, April 16, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its first quarter 2026 results on Thu...
Omada Health Earnings Call Transcript: Q4 2025
Achieved 53% revenue growth and first GAAP profitability in Q4 2025, driven by strong adoption of GLP-1 and multi-condition programs, with robust cash position and no debt. 2026 guidance reflects 22% revenue growth, excluding new product contributions.
Omada Health Announces GLP-1 Flex Care, Giving Employers a New, Flexible Path to Support Obesity Care
SAN FRANCISCO, March 05, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first provider of between-visit care, today announced GLP-1 Flex Care, a new offering that will support emplo...
Omada Health Reports Fourth Quarter and Full-Year 2025 Results
Revenue up 58% in Fourth Quarter, 53% for Year; Member Growth of 55% for Year Achieves Positive Net Income in Fourth Quarter; Significantly Narrows Net Loss for Full Year Delivers Positive Adjusted E...
Omada Adds Cholesterol Care to Its Integrated Platform, Addressing the Silent Driver of Cardiovascular Risk
SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider, today announced the expansion of its integrated platform to include ...
Omada Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 5, 2026
SAN FRANCISCO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its fourth quarter and full year 2025 ...
Omada Health Transcript: 44th Annual J.P. Morgan Healthcare Conference
Omada Health reported 52% revenue growth to $257 million and 886,000 active members, driven by multi-product offerings, strong customer demand, and expansion into GLP-1 prescribing. AI and technology investments are set to further improve margins and engagement in 2026.
Omada Health Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2025
SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced preliminary, unaudited revenue for the fourth quarter and f...
Omada Health's GLP-1 Behavior Change Companion Programs Help Drive Lasting, Long-Term Weight Loss
SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced results from a 12-month real-world analysis of memb...
Omada Health to Participate in J.P. Morgan Healthcare Conference
SAN FRANCISCO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the 4...
Omada Health Transcript: Evercore ISI 8th Annual HealthCONx Conference
A new GLP-1 prescribing track was launched to optimize weight loss outcomes and cost efficiency, with the capability designed to be accretive to revenue and margins. AI-driven tools are enhancing engagement and operational efficiency, while partnerships and multi-condition offerings are expanding market reach.
Omada Health to Participate in Evercore Healthcare Conference
SAN FRANCISCO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the 8...
Omada positioned as a Leader and Emerging Innovator in the SPARK Matrix™: Identity Governance and Administration, 2025 by QKS Group
Pune, India, Nov. 18, 2025 (GLOBE NEWSWIRE) -- QKS Group announced that it has named Omada a Technology Leader and Emerging Innovator in the analysis of the global SPARK MatrixTM: Identity Governance ...
Why Omada Health is finally prescribing Ozempic as TrumpRx slashes GLP-1 weight-loss drug costs
Trump said Thursday that TrumpRx would offer discounts on GLP-1 drugs for weight loss. A few hours later, Omada Health said it will prescribe the drugs starting in 2026.
Omada Health Earnings Call Transcript: Q3 2025
Membership and revenue surged 53% and 49% year-over-year, respectively, with first positive adjusted EBITDA and narrowed net loss. New GLP-1 prescribing, AI-driven tools, and multi-condition adoption drove growth, while 2025 guidance was raised.
Omada Health Reports Third Quarter 2025 Results
Revenue of $ 68 million, up 49% ; 53% Member Growth Significant Reduction in Net Loss and First Quarter of Positive Adjusted EBITDA Announces New GLP-1 Prescribing Offering SAN FRANCISCO, Nov. 06, 202...
Omada Health Announces GLP-1 Prescribing Capability to Support Growing Member Population
SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced the planned launch of its prescribing capability. A...
Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows
Virtual care company Omada Health said it will start prescribing GLP-1s and other obesity drugs and help patients manage those medications. The announcement expands the offerings under the company's w...
Omada Health to Present Real-World Evidence at ObesityWeek 2025 Demonstrating Enhanced Outcomes for Current and Former GLP-1 Users
SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, announced it will present two posters at ObesityWeek 2025 highlighting the ...
Omada Health Welcomes Thomas Tsang, MD, MPH as Chief Medical Officer
SAN FRANCISCO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced the appointment of Thomas Tsang, MD, MPH as Chief Medical O...
Omada Health to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 6, 2025
SAN FRANCISCO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its third quarter 2025 results on Thur...
Omada Health Launches “Meal Map,” an AI-Powered Nutrition Experience Focused on Nutrient Quality, Not Calorie Counting
The approach defies the restrictive weight loss paradigm, with early results indicating increased meal tracking and member engagement1 with new real-time, personalized nutrition guidance SAN FRANCISCO...
Omada Health Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference
The conference highlighted strong revenue growth, expanding multi-condition care, and innovative AI-driven solutions. GLP-1 cost pressures are driving customer engagement, while operational leverage and a scalable platform support long-term margin targets.
New Omada Health Analysis Shows Long-Term Weight Maintenance Post-GLP-1 Discontinuation, Challenging Industry Assumptions
SAN FRANCISCO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, released results from a real-world analysis that showed 63% of Omada membe...